Wright Medical Group (WMGI) Misses Q3 EPS by 1c; Guides FY14 Revenues Lower

Wright Medical Group (NASDAQ: WMGI) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $71.3 million versus the consensus estimate of $73 million.

Wright Medical Group sees FY2014 EPS of ($1.4)-($1.46), versus the consensus of ($1.36). The Company anticipates net sales from continuing operations, or Extremity and Biologics revenue, for 2014 of approximately $298 million to $302 million, representing growth of 23% to 25% from 2013, compared to previous guidance of $308 million to $312 million. The consensus is $303.5 million.

For earnings history and earnings-related data on Wright Medical Group (WMGI) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c